Gary Starling

Gary Starling

Astellas Pharma Inc - Tokyo / Japan
Medical and Health Sciences / Immunology
AD Scientific Index ID: 4404700
アステラス製薬株式会社
person_outline Gary Starling's MOST POPULAR ARTICLES
1-) Elotuzumab directly enhances NK cell cytotoxicity against myeloma via CS1 ligation: evidence for augmented NK cell function complementing ADCCSM Collins, CE Bakan, GD Swartzel, CC Hofmeister, YA Efebera, H Kwon, ...Cancer Immunology, Immunotherapy 62, 1841-1849, 20133082013
2-) Differential induction of apoptosis by Fas–Fas ligand interactions in human monocytes and macrophagesPA Kiener, PM Davis, GC Starling, C Mehlin, SJ Klebanoff, JA Ledbetter, ...The Journal of experimental medicine 185 (8), 1511-1516, 19973041997
3-) Human monocytic cells contain high levels of intracellular Fas ligand: rapid release following cellular activation.PA Kiener, PM Davis, BM Rankin, SJ Klebanoff, JA Ledbetter, GC Starling, ...The Journal of Immunology 159 (4), 1594-1598, 19972421997
4-) CD6—ligand interactions: a paradigm for SRCR domain function?A Aruffo, MA Bowen, DD Patel, BF Haynes, GC Starling, JA Gebe, ...Immunology today 18 (10), 498-504, 19972111997
5-) Inhibitors of HMG-CoA reductase sensitize human smooth muscle cells to Fas-ligand and cytokine-induced cell deathAC Knapp, J Huang, G Starling, PA KienerAtherosclerosis 152 (1), 217-227, 20001902000